A COVID-19 vaccine candidate developed by China's WestVac Biopharma Co Ltd has received a nod from the Nepali authorities to conduct third-phase clinical trials in the South Asian country, the Nepali government officials said.
The day after 3,000 vials of Remdesivir were imported, many COVID patients at hospitals were turned down by the hospital administration asking them to find the drug themselves.
The Department of Drug Administration has issued a notice to all concerned authorities that conditional permission has been granted for 'Emergency Use Authorisation' of SPUTNIK-V vaccine.
1639287619_480X320.png)
